Q4 2022 Torrent Pharmaceuticals Ltd Earnings Call Transcript
Ladies and gentlemen, good day, and welcome to Q4 FY '22 Earnings Call of Torrent Pharmaceuticals Limited. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Sudhir Menon. Thank you, and over to you, sir.
Yes. Thank you, [Sara]. Good evening, and welcome, everyone, to Quarter 4 FY '22 Earnings Call. Quarter 4 witnessed strong growth in the branded generic market, aided by market share gains, performance of our top brands and new launches. The branded generic markets revenue constituted 70% of our total revenue in quarter 4, which grew by around 15%.
Our financial highlights for the quarter are as follows. Revenues were INR 2,131 crores, up by 10% on a Y-o-Y basis. The gross margins were at 71%, improved by 1% on a sequential basis. The EBITDA was INR 612 crores, up by 1% on a Y-o-Y basis. The operating EBITDA margins are at 26.3%.
This quarter, we have taken a difficult decision of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
